Hepatitis C Post Liver Transplant
Showing 1 - 25 of >10,000
Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)
Active, not recruiting
- Liver Transplant
- Hepatitis C
-
Pittsburgh, PennsylvaniaUPMC
Oct 6, 2022
Hepatitis C Positive Organ to Recipient Hepatitis C Negative
Recruiting
- Liver Transplant; Complications
- Hepatitis C
-
New Haven, ConnecticutYale School of Medicine
Mar 21, 2022
Hepatitis C, Transplantation Disease Transmission Trial in United States (Sofosbuvir/Velpatasvir,
Completed
- Hepatitis C
- Transplantation Disease Transmission
-
San Francisco, California
- +5 more
Feb 10, 2021
Cirrhosis, End Stage Liver Disease, Acute Kidney Injury Trial in San Francisco, Aurora, Houston (Esophageal cooling/warming
Recruiting
- Cirrhosis
- +9 more
- Esophageal cooling/warming device
- +2 more
-
San Francisco, California
- +2 more
Jan 20, 2023
Hepatitis B Virus Reactivation:Cautionary Event After Liver
Completed
- Liver Transplant; Complications
- Diagnosis of postoperative recurrence of liver cancer
- (no location specified)
Oct 27, 2023
TruGraf Liver Gene Expression Serial Test
Not yet recruiting
- Autoimmune Liver Disease
- +3 more
- TruGraf®
- (no location specified)
Sep 27, 2023
Hepatitis B Trial (Undiluted I.V.-Hepabig inj(GC5103), Diluted I.V.-Hepabig inj(GC5103))
Not yet recruiting
- Hepatitis B
- Undiluted I.V.-Hepabig inj(GC5103)
- Diluted I.V.-Hepabig inj(GC5103)
- (no location specified)
Jan 19, 2023
Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))
Completed
- Hepatitis C
- Hepatitis C Virus Infection, Response to Therapy of
- glecaprevir/pibrentasvir (GLE/PIB)
-
San Diego, CaliforniaUniversity of California San Diego
May 23, 2022
Severe Alcoholic Hepatitis Undergoing Early Liver
Enrolling by invitation
- Liver Diseases, Alcoholic
- +6 more
- liver transplant
-
Baltimore, MarylandJohns Hopkins University
Apr 6, 2022
Liver Failure Trial in Loma Linda (Liver Transplantation)
Completed
- Liver Failure
- Liver Transplantation
-
Loma Linda, CaliforniaLoma Linda University Transplant Institute
Mar 16, 2022
Long Term Follow-up of Hepatitis C Cured Patients
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Sep 19, 2022
Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or
Active, not recruiting
- Chronic Hepatitis C
- People Who Inject Drugs
- velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
-
Atlanta, GeorgiaWellstar Atlanta Medical Center
May 31, 2023
De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
Terminated
- De Novo Autoimmune Hepatitis
- Pediatric transplant subject with d-AIH
- +6 more
- (no location specified)
Dec 9, 2021
End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])
Withdrawn
- End Stage Renal Disease
- Chronic Hepatitis c
- Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
-
Boston, MassachusettsMassachusetts General Hospital
Mar 4, 2022
Liver Transplant; Complications, Renal Complication of Procedure Trial (renal function tests)
Not yet recruiting
- Liver Transplant; Complications
- Renal Complication of Procedure
- renal function tests
- (no location specified)
Nov 7, 2023
Population in Improving Eearly Diagnosis Efficancy in Chinese
Recruiting
- Carcinoma, Hepatocellular
- +4 more
- Liver cancer surveillance every 3 months
- +2 more
-
Shanghai, Shanghai, ChinaDepartment of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)
Withdrawn
- Hepatocellular Carcinoma
- +3 more
- Elbasvir / Grazoprevir Oral Tablet
- (no location specified)
Sep 6, 2020
Liver Cirrhosis, Hepatitis C, Chronic, Epigenetic Disorder Trial in Guadalajara, Mexico City (Prolonged-Release Pirfenidone)
Recruiting
- Liver Cirrhosis
- +2 more
- Prolonged-Release Pirfenidone
-
Guadalajara, Jalisco, Mexico
- +1 more
Sep 13, 2022
Evaluation of Patients With Liver Disease
Recruiting
- Hepatitis D
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hepatitis C, Renal Insufficiency, Chronic, Disorder of Transplanted Kidney Trial in Baltimore (Post-transplant Grazoprevir and
Active, not recruiting
- Hepatitis C
- +2 more
- Post-transplant Grazoprevir and Elbasvir
-
Baltimore, MarylandUniversity of Maryland Medical Center
Oct 5, 2021
Hepatitis C in Prison: Study of Screening and Rapid Treatment
Not yet recruiting
- Chronic HIV Infection
- Xpert® HCV Viral test
- FibroScan® test
-
Paris, FranceInternal Medicine Service, Cochin Hospital (Consultation and Amb
Dec 10, 2022
Hepatocellular Carcinoma Trial in Guangzhou (TCR-T, No intervention and TCR-T (at crossover))
Completed
- Hepatocellular Carcinoma
- TCR-T
- No intervention and TCR-T (at crossover)
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun-Yat Sen University
Jun 27, 2022